Idera Pharma

IDRA NASDAQ
2.300
+0.060
+2.68%
Closed 16:00 08/21 EDT
Open
2.240
Prev Close
2.240
High
2.370
Low
2.220
Volume
107.88K
Avg Vol (3M)
253.49K
52 Week High
10.95
52 Week Low
2.080
% Turnover
0.37%
Market Cap
66.34M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Idera Pharma IDRA stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Idera Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapeutics for oncology and rare diseases. The Company utilizes two drug discovery technology platforms to design and develop drug candidates, which include Toll-like receptor (TLR) targeting technology and third-generation antisense (3GA) technology. Using TLR technology, the Company designs synthetic oligonucleotide-based drug candidates to act by modulating the activity of specific TLRs. Using its 3GA technology, the Company is developing drug candidates to turn off the messenger ribo nucleic acid (mRNA) associated with disease causing genes. The Company's drug candidates include IMO-8400, IMO-2125 and IMO-9200. The Company has designed TLR antagonists and agonists to act by modulating the activity of targeted TLRs. It is developing its 3GA technology to turn off the mRNA associated with disease causing genes.
MORE >

Recently

Name
Price
%Change